deltatrials
Completed NA INTERVENTIONAL 1-arm NCT04880837

Human Papillomavirus Education Programs

Sponsor: Ohio State University Comprehensive Cancer Center

Conditions Human Papillomavirus-Related Carcinoma
Interventions Educational Intervention Informational Intervention Survey Administration
Updated 5 times since 2021 Last updated: Oct 31, 2023 Started: Apr 27, 2022 Primary completion: Dec 31, 2022 Completion: Dec 31, 2022
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04880837, this NA trial focuses on Human Papillomavirus-Related Carcinoma and remains completed. Sponsored by Ohio State University Comprehensive Cancer Center, it has been updated 5 times since 2022, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

~Jun 2021 – ~Jun 2022 · 12 months · monthly snapshotNot Yet Recruiting~Jun 2022 – ~Dec 2023 · 18 months · monthly snapshotRecruiting~Dec 2023 – ~Jul 2024 · 7 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed NA

  2. Jul 2024 — Sep 2024 [monthly]

    Completed NA

  3. Dec 2023 — Jul 2024 [monthly]

    Completed NA

    Status: Recruiting → Completed

  4. Jun 2022 — Dec 2023 [monthly]

    Recruiting NA

    Status: Not Yet Recruiting → Recruiting

  5. Jun 2021 — Jun 2022 [monthly]

    Not Yet Recruiting NA

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Ohio State University Comprehensive Cancer Center
Data source: Ohio State University Comprehensive Cancer Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations